Wednesday - May 15, 2024

Category Archives: Pharmaceuticals & Biotech

Spinal Cord Injury Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examine DelveInsight | Kringle Pharma, Neuroplast, Abbvie, Mitsubishi Tanabe Pharma, NervGen Pharma

The Spinal Cord Injury Market report offers an in-depth understanding of the Spinal Cord Injury, historical and forecasted epidemiology as well as the Spinal Cord Injury market trends in the 7MM. DelveInsight’s “Spinal Cord Injury Market Insights, Epidemiology, and Market … Continue reading →

Non-Alcoholic Steatohepatitis Market to Register Incremental Growth During the Forecast Period (2024-2034), Asserts DelveInsight | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking

The Non-Alcoholic Steatohepatitis Market size was valued approximately USD 1,634 million in 2022 and the report offers an in-depth understanding of the Non-Alcoholic Steatohepatitis, historical and forecasted epidemiology as well as the Non-Alcoholic Steatohepatitis market trends in the 7MM. DelveInsight’s … Continue reading →

ESR1 Mutated Metastatic Breast Cancer Market and Epidemiology 2032: Treatment Market, Therapies, FDA Approval, Epidemiology & Forecast by DelveInsight | Sanofi, Sun Pharma, Pfizer, Arvinas, Zenopharm

The ESR1 Mutated Metastatic Breast Cancer Market Forecast report offers an in-depth understanding of the ESR1 Mutated Metastatic Breast Cancer, historical and forecasted epidemiology as well as the ESR1 Mutated Metastatic Breast Cancer market trends in the 7MM. ESR1 Mutated … Continue reading →

Myasthenia Gravis Market to Exhibit Remarkable Growth During the Forecast Period (2024-2034), Analyzes DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen

The Myasthenia Gravis Market size was valued approximately USD 3,880 million in 2023 and the report offers an in-depth understanding of the Myasthenia Gravis, historical and forecasted epidemiology as well as the Myasthenia Gravis market trends in the 7MM. DelveInsight’s … Continue reading →

Degenerative Disc Disease Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutics, BIOPHARM

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Degenerative Disc Disease pipeline constitutes 15+ key companies continuously working towards developing 15+ Degenerative Disc Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Vascular Ehlers-Danlos Syndrome Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Pipeline Drugs, Epidemiology and Companies by DelveInsight

Vascular Ehlers-Danlos Syndrome Market The Vascular Ehlers-Danlos Syndrome market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Vascular Ehlers-Danlos Syndrome pipeline products will significantly revolutionize the Vascular Ehlers-Danlos … Continue reading →

Non-Cystic Fibrosis Bronchiectasis Pipeline Assessment 2024: FDA, EMA, PDMA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | NP339, CHF 6333, CSL787, HSK31858, S-1226, Benralizumab

Non-Cystic Fibrosis Bronchiectasis Pipeline As per DelveInsight’s assessment, globally, Non-Cystic Fibrosis Bronchiectasis pipeline constitutes 16+ key companies continuously working towards developing 17+ Non-Cystic Fibrosis Bronchiectasis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments … Continue reading →

Migraine Market Forecast 2034: FDA, EMA, PDMA Approvals, Clinical Trials, Therapies, Epidemiology and Companies by DelveInsight | AIMOVIG, Fremanezumab, LBR-101, Atogepant, Galcanezumab, Eptinezumab

Migraine Market Migraine Companies are Amgen, Teva Pharmaceuticals, Eli Lilly and Company, Anne Lindblad, Allergan, Teva Branded Pharmaceutical, AbbVie, Tian Medical Inc., Allergan, Eli Lilly and Company, H. Lundbeck A/S, Tonix Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., and others. (Albany, USA) … Continue reading →

Post-Bariatric Hypoglycemia Market Forecast 2032: FDA, EMA, PDMA Approvals, Clinical Trials, Therapies, Epidemiology and Companies by DelveInsight | Pasireotide Diaspartate, glucagon, Lyo avexitide

Post-Bariatric Hypoglycemia Market Post-Bariatric Hypoglycemia companies are XOMA, Zealand Pharma A/S, Eiger BioPharmaceuticals, Xeris Pharmaceuticals, Inc, Bayer, Emcure Pharmaceuticals, Virtus, Mylan N.V., Strides Pharma Science Limited, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC, Pfizer Inc, Exela Pharma Sciences, LLC, Novartis … Continue reading →

Primary Sclerosing Cholangitis Pipeline Assessment 2024: FDA, EMA, PDMA Approvals, Clinical Trials, Therapies, MOA, ROA and Companies by DelveInsight | GRI-0124, QBT-002, STP707, CS0159, CM 101, more

Primary Sclerosing Cholangitis Pipeline As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments … Continue reading →